Natco adds two product drugs to US sale pact

3950 Investors following Natco Pharma. Share this News with them.

0

Like this story, share it with millions of investors on M3

Natco adds two product drugs to US sale pact

Natco Pharma Ltd. said on Friday it has added two injectible drugs for sale in the United States under an existing marketing tie-up with Akorn Inc, reports Reuters.

Post your opinion here

 

0

Tweet

Share on Tumblr

ALSO READ See latest News about Natco Pharma See previous management interviews See what other Experts & Brokerages are saying about Natco Pharma Natco Pharma BSE | NSE 25/05/12 Are Mutual Funds betting on Natco Pharma?

Natco Pharma Ltd . said on Friday it has added two injectible drugs for sale in the United States under an existing marketing tie-up with Akorn Inc, reports Reuters.

The drugs are used in the prevention of nausea and vomiting associated with chemotherapy.

With this, the total number of products sold under the tie-up had risen to four, including two other oncology products, the Indian company said in a statement.

Akorn also files abbreviated new drug applications for Natco's bulk drugs on a profit-sharing basis.